Related Experiment Videos
Embryotoxicity as a marker for recurrent pregnancy loss
1Nuffield Department of Obstetrics and Gynaecology, University of Oxford, John Radcliffe Hospital, United Kingdom.
Summary
Serum embryotoxic factors may cause recurrent pregnancy loss. These factors, potentially immunological or nutritional, can affect early embryo development and may be treatable with immunotherapy.
Area of Science:
- Reproductive immunology
- Developmental toxicology
- Infertility research
Background:
- Unexplained recurrent pregnancy loss (RPL) is a significant reproductive health issue.
- Embryotoxic factors in maternal serum are suspected contributors to RPL.
- Existing research indicates a need to identify and characterize these factors.
Purpose of the Study:
- To investigate the presence and effect of embryotoxic factors in maternal serum.
- To assess the potential of these factors to predict pregnancy outcomes.
- To explore therapeutic interventions for conditions associated with embryotoxic activity.
Main Methods:
- Utilized in vitro assays to assess the impact of maternal serum on rodent embryos at various developmental stages (pre-implantation, peri-implantation, somite stage).
- Analyzed serum from women with recurrent pregnancy loss, endometriosis, and unexplained infertility.
- Monitored pregnancy outcomes in relation to embryotoxic activity levels.
Main Results:
- High prevalence of embryotoxic activity detected in women with recurrent pregnancy loss.
- Embryotoxic activity also observed in women with endometriosis and unexplained infertility, suggesting diverse origins.
- Embryotoxic activity showed potential as a predictor of pregnancy outcomes.
- Hormone therapy and immunotherapy demonstrated a reduction in embryotoxic activity.
Conclusions:
- Embryotoxic factors in maternal serum are implicated in recurrent pregnancy loss and other reproductive challenges.
- Further characterization of these factors, potentially immunological (antibodies, cytokines) or nutritional, is crucial.
- Therapeutic strategies like immunotherapy may mitigate the effects of these factors, improving pregnancy outcomes.